Skip to main content

Table 4 Effects of gabexate mesilate on the outcome of the patients

From: A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis

 

Survivors

Nonsurvivors

Mortality (%)

Pvalue

Gabexate mesilate and antithrombin

14

2

12.5

 

Gabexate mesilate

15

2

11.8

 
    

1.000

Use of gabexate mesilate

29

4

12.1

 

Nonuse of gabexate mesilate

24

3

11.1

 
    

1.000

Back to article page

Critical Care

ISSN: 1364-8535